Abstract: Every medication comes with two types of medical facts: indications, which describe what conditions the drug treats (benefits), and contraindications, which describe who must avoid it to prevent serious harm (safety limits). Although contraindications are critical for patient safety and FDA regulations require listing them as rigorously as indications, we find that contraindications are far less documented than indications in general prose. In this paper, we measure how often these texts contain both facts across 574 drugs from PrimeKG by comparing a drug's indications against its own contraindications. Across Wikipedia articles and PubMed abstracts, we find that reference prose names a drug's benefits about twice as often as its safety limits (within-drug odds ratio 2.19). We call this documentation gap LABEL (Literature Asymmetry between Efficacy and Limits). Language models mirror this gap. As we scale Qwen2.5 from 0.5B to 14B, accuracy on indications rises by 18.3 points, whereas accuracy on contraindications remains flat near random guessing. However, when we provide models with a retrieved passage that states the answer, they use safety facts just as effectively as benefits. Furthermore, routing safety questions to official FDA labels boosts accuracy by 15.8 points whenever the label states the fact. Overall, our findings show that models fail on medication safety not because they cannot reason about risk, but because free-text corpora lack safety facts. Clinical AI systems should therefore route medication-safety questions to official regulatory labels and structured databases rather than relying on general public records. Code and data are available at https://github.com/SMRayeed/LABEL.
Read the original article:
LABEL: Literature Asymmetry between Efficacy and Limits in Drug Knowledge and Language Models
